Intrinsic Value of S&P & Nasdaq Contact Us

HeartBeam, Inc. BEATW NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
44/100
2/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

HeartBeam, Inc. (BEATW) has a negative trailing P/E of -1.9, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 0.4 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -52.83%, forward earnings yield 256.41%.

Criteria proven by this page:

  • VALUE (100/100, Pass) — composite valuation score exceeds the 60/100 pass threshold.
  • Forward P/E 0.4 — analysts expect a return to profitability with estimated EPS of $0.30 for FY2029.
  • Trailing Earnings Yield -52.83% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 256.41% as earnings recover.

Overall SharesGrow Score: 41/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
44/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
N/A
No coverage
PAST
0/100
→ Income
HEALTH
75/100
Debt-to-Equity & liquidity
→ Health
MOAT
28/100
→ Income
GROWTH
15/100
→ Income
INCOME
N/A
No coverage

Valuation Snapshot — BEATW

Valuation Multiples
P/E (TTM)-1.9
Forward P/E0.4
PEG RatioN/A
Forward PEG0.00
P/B Ratio15.28
P/S Ratio0.00
EV/EBITDA-1.7
Per Share Data
EPS (TTM)$-0.62
Forward EPS (Est.)$0.30
Book Value / Share$0.08
Revenue / Share$0.00
FCF / Share$-0.43
Yields & Fair Value
Earnings Yield-52.83%
Forward Earnings Yield256.41%
Dividend Yield0.00%

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 2.5 0.00 0.94 0.63 -
2017 -8.9 0.07 0.57 0.50 -
2018 3.9 -0.01 0.54 0.42 -
2019 -71.5 0.66 -10.28 0.00 -
2020 -35.9 -0.76 -8.01 0.00 -
2021 -5.4 -0.02 1.79 0.00 -
2022 -3.1 -0.02 16.79 0.00 -
2023 -3.3 0.06 3.00 0.00 -
2024 -3.2 -2.27 37.05 0.00 -
2025 -3.8 0.26 31.08 0.00 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $1.75 $208.33M $53.44M 25.6%
2017 $-0.53 $286.78M $-15.96M -5.6%
2018 $1.20 $399.47M $42.82M 10.7%
2019 $-0.10 $0.00 $-778K -
2020 $-0.17 $0.00 $-1.07M -
2021 $-1.03 $0.00 $-4.43M -
2022 $-1.59 $0.00 $-12.96M -
2023 $-0.72 $0.00 $-14.64M -
2024 $-0.73 $0.00 $-19.45M -
2025 $-0.62 $0.00 $-21.02M -

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-0.52 $-0.87 – $-0.29 $2.39M $685.52K – $4.34M 1
2027 $-0.40 $-0.67 – $-0.22 $8.67M $6.43M – $12.44M 1
2028 $-0.20 $-0.33 – $-0.11 $26.56M $17.26M – $40.18M 1
2029 $0.42 $0.23 – $0.70 $73.38M $47.67M – $111M 1
2030 $0.84 $0.46 – $1.40 $127.73M $82.99M – $193.22M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message